Literature DB >> 18321929

Sex differences in physiological progression of idiopathic pulmonary fibrosis.

M K Han1, S Murray, C D Fell, K R Flaherty, G B Toews, J Myers, T V Colby, W D Travis, E A Kazerooni, B H Gross, F J Martinez.   

Abstract

In idiopathic pulmonary fibrosis, incidence is higher in males, and females may have better survival. The aim of the present study was to determine whether the rate of increase in desaturation during serial 6-min walk testing would be greater, and survival worse, for males versus females. Serial changes in the percentage of maximum desaturation area (DA) over 1 yr were estimated using mixed models in 215 patients. DA was defined as the total area above the curve created using desaturation percentage values observed during each minute of the 6-min walk test. Multivariate Cox regression assessed survival differences. Adjusting for baseline DA, 6-min walk distance, change in 6-min walk distance over time and smoking history, the percentage of maximum DA increased by an average of 2.83 and 1.37% per month for males and females, respectively. Females demonstrated better survival overall, which was more pronounced in patients who did not desaturate below 88% on ambulation at baseline and after additionally adjusting for 6-month relative changes in DA and forced vital capacity. These data suggest that differences in disease progression contribute to, but do not completely explain, better survival of females with idiopathic pulmonary fibrosis.

Entities:  

Mesh:

Year:  2008        PMID: 18321929     DOI: 10.1183/09031936.00165207

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis.

Authors:  Sean P McGee; Hongmei Zhang; Wilfried Karmaus; Tara Sabo-Attwood
Journal:  Int J Mol Epidemiol Genet       Date:  2014-05-29

2.  Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.

Authors:  MeiLan K Han; Yueren Zhou; Susan Murray; Nabihah Tayob; Imre Noth; Vibha N Lama; Bethany B Moore; Eric S White; Kevin R Flaherty; Gary B Huffnagle; Fernando J Martinez
Journal:  Lancet Respir Med       Date:  2014-04-21       Impact factor: 30.700

Review 3.  Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Ivan O Rosas; Paul F Dellaripa; David J Lederer; Dinesh Khanna; Lisa R Young; Fernando J Martinez
Journal:  Ann Am Thorac Soc       Date:  2014-04

4.  Sex and Gender Differences in Lung Disease.

Authors:  Patricia Silveyra; Nathalie Fuentes; Daniel Enrique Rodriguez Bauza
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.

Authors:  Helen E Jo; Sharan Randhawa; Tamera J Corte; Yuben Moodley
Journal:  Drugs Aging       Date:  2016-05       Impact factor: 3.923

6.  Multi-walled carbon nanotubes inhibit estrogen receptor expression in vivo and in vitro through transforming growth factor beta1.

Authors:  L Cody Smith; Santiago Moreno; Sarah Robinson; Marlene Orandle; Dale W Porter; Dipesh Das; Navid B Saleh; Tara Sabo-Attwood
Journal:  NanoImpact       Date:  2019-03-21

7.  The natural history of idiopathic pulmonary fibrosis in a large European population: the role of age, sex and comorbidities.

Authors:  Antonella Caminati; Fabiana Madotto; Sara Conti; Giancarlo Cesana; Lorenzo Mantovani; Sergio Harari
Journal:  Intern Emerg Med       Date:  2021-02-14       Impact factor: 3.397

Review 8.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

9.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

10.  A retrospective study of prognostic factors in patients with interstitial pneumonia receiving long-term oxygen therapy.

Authors:  Masayoshi Higashiguchi; Takashi Kijima; Hiromitsu Sumikawa; Osamu Honda; Toshiyuki Minami; Haruhiko Hirata; Koji Inoue; Izumi Nagatomo; Yoshito Takeda; Hiroshi Kida; Noriyuki Tomiyama; Atsushi Kumanogoh
Journal:  Lung       Date:  2014-07-24       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.